Promoter Hypomethylation Results in Increased Expression of Protein Phosphatase 2A in T Cells from Patients with Systemic Lupus Erythematosus
暂无分享,去创建一个
G. Tsokos | V. Kyttaris | Y. Juang | George C Tsokos | Vasileios C Kyttaris | Katsue Sunahori | Yuang-Taung Juang | K. Sunahori | Katsue Sunahori
[1] A. Perl,et al. Abnormal T cell signal transduction in systemic lupus erythematosus. , 2002, Arthritis and rheumatism.
[2] J. Harley,et al. Unraveling the genetics of systemic lupus erythematosus , 2006, Springer Seminars in Immunopathology.
[3] D. Virshup,et al. Protein phosphatase 2A: a panoply of enzymes. , 2000, Current opinion in cell biology.
[4] Mariana J. Kaplan,et al. Demethylation of Promoter Regulatory Elements Contributes to Perforin Overexpression in CD4+ Lupus T Cells1 , 2004, The Journal of Immunology.
[5] P. Jagodziński,et al. MTR 2756 A > G polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population , 2007, Lupus.
[6] Q. Lu,et al. T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. , 2009, Clinical immunology.
[7] G. Tsokos,et al. Methylation Status of CpG Islands Flanking a cAMP Response Element Motif on the Protein Phosphatase 2Acα Promoter Determines CREB Binding and Activity1 , 2009, The Journal of Immunology.
[8] Nam-Hee Kwon,et al. DNA methylation and the expression of IL-4 and IFN-gamma promoter genes in patients with bronchial asthma. , 2008, Journal of clinical immunology.
[9] J. Hansen,et al. Recent Advances in Mecp2 Structure and Function Introduction: a Historical Perspective of Mecp2 Structure and Function , 2022 .
[10] Y. Takasaki,et al. DNA methylation: its contribution to systemic lupus erythematosus , 2006, Clinical and Experimental Medicine.
[11] Yuanjia Tang,et al. MicroRNA-21 and MicroRNA-148a Contribute to DNA Hypomethylation in Lupus CD4+ T Cells by Directly and Indirectly Targeting DNA Methyltransferase 1 , 2010, The Journal of Immunology.
[12] G L Johnson,et al. Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation , 1993, Molecular and cellular biology.
[13] M. Vilardell‐Tarrés,et al. Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus , 2008, Immunology.
[14] G. Muszyńska,et al. Protein phosphatase 2A: variety of forms and diversity of functions. , 2001, Acta biochimica Polonica.
[15] A. Wolffe,et al. How does DNA methylation repress transcription? , 1997, Trends in genetics : TIG.
[16] G. Cooper,et al. Occupational risk factors for the development of systemic lupus erythematosus. , 2004, The Journal of rheumatology.
[17] R. Read,et al. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. , 2008, Arthritis and rheumatism.
[18] Christopher B Wilson,et al. Epigenetic control of T-helper-cell differentiation , 2009, Nature Reviews Immunology.
[19] B. Richardson,et al. Role of DNA methylation in the regulation of cell function. , 1999, The Journal of laboratory and clinical medicine.
[20] V. Janssens,et al. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. , 2001, The Biochemical journal.
[21] M. Nakao,et al. Genomic imprinting: significance in development and diseases and the molecular mechanisms. , 1996, Journal of biochemistry.
[22] Y. Khew-Goodall,et al. Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. , 1991, Biochemistry.
[23] L. Audoly,et al. Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE , 2007, Nature Immunology.
[24] G. Tsokos,et al. PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells. , 2008, Journal of immunology.
[25] Q. Lu,et al. Demethylation of CD40LG on the Inactive X in T Cells from Women with Lupus1 , 2007, The Journal of Immunology.
[26] A. Sawalha,et al. Impaired T Cell Protein Kinase Cδ Activation Decreases ERK Pathway Signaling in Idiopathic and Hydralazine-Induced Lupus1 , 2007, The Journal of Immunology.
[27] Q. Lu,et al. Demethylation of the Same Promoter Sequence Increases CD70 Expression in Lupus T Cells and T Cells Treated with Lupus-Inducing Drugs1 , 2005, The Journal of Immunology.
[28] H. Shin,et al. Association analyses of DNA methyltransferase-1 (DNMT1) polymorphisms with systemic lupus erythematosus , 2004, Journal of Human Genetics.
[29] C. Matouk,et al. Epigenetic Regulation of Vascular Endothelial Gene Expression , 2008, Circulation research.
[30] P. Janson,et al. CpG methylation of the IFNG gene as a mechanism to induce immunosuppression [correction of immunosupression] in tumor-infiltrating lymphocytes. , 2008, Journal of immunology.
[31] B. Richardson,et al. Aberrant T cell ERK pathway signaling and chromatin structure in lupus. , 2009, Autoimmunity reviews.
[32] B. Richardson,et al. Epigenetic mechanisms in lupus , 2010, Current opinion in rheumatology.
[33] Peter A. Jones,et al. Epigenetics in cancer. , 2010, Carcinogenesis.
[34] A. Schönthal,et al. Autoregulation of Protein Phosphatase Type 2A Expression* , 1998, The Journal of Biological Chemistry.
[35] N. Knowlton,et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients , 2008, Genes and Immunity.
[36] F. Zeng,et al. Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients , 2008, Acta Pharmacologica Sinica.
[37] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[38] S. Akira,et al. Requirement for DNA CpG Content in TLR9-Dependent Dendritic Cell Activation Induced by DNA-Containing Immune Complexes1 , 2009, The Journal of Immunology.
[39] Q. Lu,et al. Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. , 2010, Journal of autoimmunity.
[40] J. Harley,et al. Antinuclear autoantibodies in systemic lupus erythematosus , 2004, Current opinion in rheumatology.
[41] P. Janson,et al. CpG Methylation of the IFNG Gene as a Mechanism to Induce Immunosupression in Tumor-Infiltrating Lymphocytes1 , 2008, The Journal of Immunology.
[42] Zhiyong Zhang,et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. , 2003, Arthritis & Rheumatism.
[43] Nam-Hee Kwon,et al. DNA Methylation and the Expression of IL-4 and IFN-γ Promoter Genes in Patients with Bronchial Asthma , 2008, Journal of Clinical Immunology.
[44] A. Sawalha,et al. Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. , 2009, Translational research : the journal of laboratory and clinical medicine.
[45] D. Gutsch,et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. , 2002, Arthritis and rheumatism.
[46] G. Tsokos,et al. Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. , 2005, The Journal of clinical investigation.
[47] P. Molloy,et al. DNA hypomethylation and human diseases. , 2007, Biochimica et biophysica acta.
[48] P. Jagodziński,et al. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus. , 2004, Journal of applied genetics.
[49] G. Tsokos,et al. PP2A Dephosphorylates Elf-1 and Determines the Expression of CD3ζ and FcRγ in Human Systemic Lupus Erythematosus T Cells1 , 2008, The Journal of Immunology.
[50] J. Götz,et al. Altered phosphorylation of cytoskeletal proteins in mutant protein phosphatase 2A transgenic mice. , 2006, Biochemical and biophysical research communications.
[51] A. Jeltsch,et al. Biochemistry and biology of mammalian DNA methyltransferases , 2004, Cellular and Molecular Life Sciences CMLS.
[52] J. Hofsteenge,et al. Molecular cloning of cDNAs encoding two isoforms of the catalytic subunit of protein phosphatase 2A. , 1987, Biochemistry.
[53] S. Hanash,et al. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. , 1988, Journal of immunology.
[54] S. Hanash,et al. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. , 1992, Arthritis and rheumatism.
[55] H. Hashimoto,et al. Possible role of DNA hypomethylation in the induction of SLE: relationship to the transcription of human endogenous retroviruses. , 2003, Clinical and experimental rheumatology.
[56] K. Aho,et al. Twin studies in rheumatic diseases. , 1994, Seminars in arthritis and rheumatism.
[57] J. Pers,et al. Epigenetics and autoimmunity. , 2010, Journal of autoimmunity.
[58] M. Bartolomei,et al. Genomic imprinting in mammals. , 1997, Annual review of genetics.
[59] Xiangpei Li,et al. Ultraviolet B exposure of peripheral blood mononuclear cells of patients with systemic lupus erythematosus inhibits DNA methylation , 2009, Lupus.
[60] Shizhong Han,et al. Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus , 2008, PloS one.
[61] A. Sawalha. Epigenetics and T-cell immunity , 2008, Autoimmunity.
[62] B. Richardson,et al. Environmentally induced autoimmune diseases: potential mechanisms. , 1999, Environmental health perspectives.
[63] Andrew I Su,et al. Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. , 2003, Molecular cell.
[64] D. Sackett,et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.
[65] Fatima Al-Shahrour,et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. , 2010, Genome research.
[66] S. Hanash,et al. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. , 2001, Arthritis and rheumatism.